Healthcare -
Biotechnology - NASDAQ - US
$ 11.87
-0.785 %
$ 172 M
Market Cap
0.1
P/E
INBX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities INBX - Inhibrx Biosciences, Inc.
-2.6 M
LAST VALUE
-94.57%
2 YEAR CAGR
-7.49%
5 YEAR CAGR
0.00%
10 YEAR CAGR